Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
Top Cited Papers
Open Access
- 4 March 2021
- Vol. 13 (5), 1102
- https://doi.org/10.3390/cancers13051102
Abstract
Within aggressive malignancies, there usually are the “hypoxic zones”—poorly vascularized regions where tumor cells undergo oxygen deficiency through inadequate blood supply. Besides, hypoxia may arise in tumors as a result of antiangiogenic therapy or transarterial embolization. Adapting to hypoxia, tumor cells acquire a hypoxia-resistant phenotype with the characteristic alterations in signaling, gene expression and metabolism. Both the lack of oxygen by itself and the hypoxia-responsive phenotypic modulations render tumor cells more radioresistant, so that hypoxic tumors are a serious challenge for radiotherapy. An understanding of causes of the radioresistance of hypoxic tumors would help to develop novel ways for overcoming this challenge. Molecular targets for and various approaches to radiosensitizing hypoxic tumors are considered in the present review. It is here analyzed how the hypoxia-induced cellular responses involving hypoxia-inducible factor-1, heat shock transcription factor 1, heat shock proteins, glucose-regulated proteins, epigenetic regulators, autophagy, energy metabolism reprogramming, epithelial–mesenchymal transition and exosome generation contribute to the radioresistance of hypoxic tumors or may be inhibited for attenuating this radioresistance. The pretreatments with a multitarget inhibition of the cancer cell adaptation to hypoxia seem to be a promising approach to sensitizing hypoxic carcinomas, gliomas, lymphomas, sarcomas to radiotherapy and, also, liver tumors to radioembolization.Keywords
This publication has 347 references indexed in Scilit:
- The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate DehydrogenaseCell Metabolism, 2013
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell linesCell Death & Disease, 2013
- Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 ActivationEvidence-Based Complementary and Alternative Medicine, 2013
- Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vesselsNature Communications, 2012
- E-Cadherin loss associated with EMT promotes radioresistance in human tumor cellsRadiotherapy and Oncology, 2011
- Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2αOnline Journal of Public Health Informatics, 2010
- Heat Shock Protein 27 as a New Therapeutic Target for Radiation Sensitization of Head and Neck Squamous Cell CarcinomaMolecular Therapy, 2009
- Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapyBritish Journal of Cancer, 2009
- Radiation‐induced HIF‐1α cell survival pathway is inhibited by soy isoflavones in prostate cancer cellsInternational Journal of Cancer, 2009
- Regulation of HIF-1α Stability through S-NitrosylationMolecular Cell, 2007